ENDRA Life Sciences (NDRA) Non Operating Income (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Non Operating Income of $862315.0 for Q1 2026, up 99.17% year-over-year from $432952.0 in Q1 2025, and up 164.17% quarter-over-quarter from -$1.3 million in Q4 2025.
ENDRA Life Sciences (NDRA) Non Operating Income (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Non Operating Income data on file, last reported at $862315.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $862315.0, up 99.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$693658.0 (down 154.2% YoY), and the FY2025 annual result was -$1.3 million, down 2046.53% from the prior year.
- Non Operating Income improved to $862315.0 in Q1 2026 per NDRA's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Non Operating Income peaked at $862315.0 in Q1 2026 and troughed at -$1.3 million in Q4 2025.
- A 5-year average of $33900.1 and a median of $4841.0 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Non Operating Income sank 2043.41% in 2023, then soared 8843.44% in 2025.
- A 5-year view of Non Operating Income shows it stood at $23785.0 in 2022, then slumped by 2043.41% to -$462241.0 in 2023, then surged by 268.66% to $779635.0 in 2024, then slumped by 272.36% to -$1.3 million in 2025, then surged by 164.17% to $862315.0 in 2026.
- Business Quant data shows NDRA's Non Operating Income at $862315.0 in Q1 2026, -$1.3 million in Q4 2025, and -$225256.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 1.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | -9.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -73.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | -4.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 9.60 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -52.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 7.33 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | 862,315.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 862,315.00 |
| Dec 31, 2025 | -1.34 Mn |
| Sep 30, 2025 | -225,256.00 |
| Jun 30, 2025 | 13,066.00 |
| Mar 31, 2025 | 432,952.00 |
| Dec 31, 2024 | 779,635.00 |
| Sep 30, 2024 | 65,528.00 |
| Jun 30, 2024 | 1,700.00 |
| Mar 31, 2024 | 4,841.00 |
| Dec 31, 2023 | -462,241.00 |
| Sep 30, 2023 | 28,226.00 |
| Jun 30, 2023 | 437,433.00 |
| Mar 31, 2023 | 3,418.00 |
| Dec 31, 2022 | 23,785.00 |
| Sep 30, 2022 | -23,011.00 |
| Jun 30, 2022 | -19,374.00 |
| Mar 31, 2022 | -2,933.00 |
| Dec 31, 2021 | -33,087.00 |
| Sep 30, 2021 | -7,507.00 |
| Jun 30, 2021 | 1,086.00 |